Evidence map›Paper›PMID 29237739›Full record

ReviewJournal of the American Society of Nephrology : JASN2018

Salt-Losing Tubulopathies in Children: What's New, What's Controversial?

Robert Kleta, Detlef Bockenhauer

Open access · greenAbstract readReview
In one paragraph

Review in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Dent disease: clinical practice recommendations.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Guideline
  2. Failure to thrive in children with tubulopathies.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Renal Hypokalemia: An Endocrine Perspective.The Journal of clinical endocrinology and metabolism · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Inherited Fanconi syndrome.World journal of pediatrics : WJP · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Robert KletaUCL Centre for Nephrology and Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom.ORCID 0000-0002-0228-8656
Detlef BockenhauerUCL Centre for Nephrology and Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom d.bockenhauer@ucl.ac.uk.ORCID 0000-0001-5878-941X
Great Ormond Street Hospital · GBGreat Ormond Street Hospital for Children NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal tubulopathies provide insights into the inner workings of the kidney, yet also pose therapeutic challenges. Because of the central nature of sodium in tubular transport physiology, disorders of sodium handling may affect virtually all aspects of the homeostatic functions of the kidney. Yet, owing to the rarity of these disorders, little clinical evidence regarding treatment exists. Consequently, treatment can vary widely between individual physicians and centers and is based mainly on understanding of renal physiology, reported clinical observations, and individual experiences. Salt-losing tubulopathies can affect all tubular segments, from the proximal tubule to the collecting duct. But the more frequently observed disorders are Bartter and Gitelman syndrome, which affect salt transport in the thick ascending limb of Henle's loop and/or the distal convoluted tubule, and these disorders generate the greatest controversies regarding management. Here, we review clinical and molecular aspects of salt-losing tubulopathies and discuss novel insights provided mainly by genetic investigations and retrospective clinical reviews. Additionally, we discuss controversial topics in the management of these disorders to highlight areas of importance for future clinical trials. International collaboration will be required to perform clinical studies to inform the treatment of these rare disorders.

Indexed as

Renal ReabsorptionAdaptor Proteins, Signal TransducingAdolescentAntigens, NeoplasmBartter SyndromeChildChild, PreschoolFanconi SyndromeGitelman SyndromeHumansInfantInfant, NewbornKidney TubulesSodium ChlorideSolute Carrier ProteinsAdaptor Proteins, Signal TransducingAntigens, NeoplasmMAGED2 protein, humanSodium ChlorideSolute Carrier ProteinsBartter-s syndromeCell & Transport PhysiologychildrenGitelman-s syndromekidney tubule

Identifiers

PMID29237739
PMCPMC5827598
OpenAlexW2775793594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.